Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
233.59
+4.26 (1.86%)
May 26, 2026, 1:39 PM EDT - Market open

Ligand Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,6813,7392,0471,2541,1322,590
Market Cap Growth
137.16%82.62%63.27%10.73%-56.28%61.95%
Enterprise Value
4,2773,4561,7971,089930.792,572
Last Close Price
233.59189.07107.1571.4266.80154.46
PE Ratio
31.1530.84-24.29-46.66
Forward PE
44.7735.2053.5835.07--
PEG Ratio
2.332.423.572.34--
PS Ratio
16.7813.9512.259.555.7710.72
PB Ratio
4.613.682.471.791.903.15
P/TBV Ratio
4.783.772.361.811.893.24
P/FCF Ratio
37.4376.4421.5027.229.4436.98
P/OCF Ratio
37.2875.7421.1025.298.2132.87
EV/Sales Ratio
15.5812.8910.758.304.7410.65
EV/EBITDA Ratio
31.8146.21142.2423.5117.0616.60
EV/EBIT Ratio
42.2584.28-110.92306.4824.76
EV/FCF Ratio
34.7670.6618.8723.657.7636.72
Debt / Equity Ratio
0.450.440.010.010.020.39
Debt / EBITDA Ratio
3.546.040.560.131.612.09
Debt / FCF Ratio
3.679.230.070.130.734.63
Net Debt / Equity Ratio
-0.33-0.28-0.30-0.23-0.21-0.02
Net Debt / EBITDA Ratio
-2.56-3.77-19.72-3.54-2.27-0.11
Net Debt / FCF Ratio
-2.66-5.77-2.62-3.56-1.03-0.24
Asset Turnover
0.180.210.190.170.190.18
Inventory Turnover
1.161.250.580.562.602.31
Quick Ratio
20.4821.187.9412.112.4510.24
Current Ratio
21.2822.238.9314.152.6711.15
Return on Equity (ROE)
23.21%13.47%-0.53%8.29%-0.74%9.98%
Return on Assets (ROA)
7.06%3.95%-4.89%1.45%0.63%7.20%
Return on Invested Capital (ROIC)
14.49%6.84%-6.74%1.98%0.89%10.30%
Return on Capital Employed (ROCE)
6.28%3.38%-2.70%1.37%0.32%8.25%
Earnings Yield
3.34%3.24%-4.12%-2.14%
FCF Yield
2.67%1.31%4.65%3.67%10.59%2.70%
Buyback Yield / Dilution
-9.71%-10.96%-3.00%-5.27%2.19%-2.50%
Total Shareholder Return
-9.71%-10.96%-3.00%-5.27%2.19%-2.50%
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q